what happend if the person takes two different types vaccines , simply way to tell you a information about vaccines #UPSC #IAS #CUURENT AFFAIRS #SPUTNIK V https://www.lifeguidessss.com/2021/05/third-covid-vaccine-launched-in-india.html

1. Third covidvaccine launchedinINDIA , simplywaytotell youa informationaboutvaccines
Now14 may day sputnikV vaccine launchedinindia how muchitwill costpayfor ? tell youall
informationaboutthis
The labo.Has a bighandto make thishappenedin india,DRReddy’slaboratorieshadlaunched
sputnikV inindia, the vaccine iscurrentlythe secondmostexpensive covid -19jabinthe country.
What isthe science behindthis sputnikV forcovidor how sputnik workagainstcovid,everypeople
have a questioninhismindIam explainthis simply”
What is sputnikV ?
IT IS made by the gemaleyaresearchinstitute of epidemiologyandmicrobiologyinMoscow,sputnik
V isa twoshot covidvaccine usinga similarplatformtocovishieldthe mostwidelyusedvaccine in
indiasince the government;simmunisationprogramme beganinJanuary.
However,unlike covishield,whichusesaweakenedcommoncoldadenovirusthataffects
chimpanzeessputnikV makesuses of twodifferenthumanadenovirus, adenovirusisadnavirus,
thiscausesor produces a common cold in humans,ina weekformanduse as a vector is like
somethinglikeacar , like we senda code a for S protine thenloadcomestovector thencomes in
body, afterwhenitis comesinbodythenbodystart reactingandgentrate a immunitysystemand
start a makinganti bodyinhumans, thisthe way sputnikV vaccine readyforcovid.
The vaccine holdhasa efficacyof over91 percentinaccording to a publicationinscientificjournal
data of the lancet.
This meansithas the abilitytobringdownsysmptomaticcovidcasesbyover91 percent inthose
vaccinatedcomparedwiththose whohave notreceivedacovidvaccine,
Where wassputnikV launched inindia?
Followingclearancesfromthe central druglaboratory,whichperformedvarioustestsonthis
vaccinesqualityandstability,the firstdose of sputnikV wasadministeredinHyderabad.,

2. How manydoseswill sputnikaddtoindia’svaccinationefforts?
So far the DRL has onlyreceived150000 dosesof thisvaccinesfromRussia,the companyexperts
more dosessoon,inaccordingto its agreementwiththe Russiandirectinvestmentfund( RDIF)
whichhas beenincharge of signingagreementsforsupplyforthisvaccine acrossthe world, we
think, indiaisexpertedtogetatleast250 milliondoseswhichwill be sufficienttoinoculate 125
millionpeople,howeveritisunclearbywhenthese doseswill be suppliedanddistributedinindia.
Capacity to make around 850 milliandosesof the vaccinesisalsobeingsetupinindiathroughpacts
inkedwithvariousbiotechnologycompanies,the companyisworkingcloselywithitsix
manufacturing partnersinindiatofull fill regulatoryreqirmenttoensure smoothandtimelysupply,
DR reddy’swill workcloselywithstakeholdersinthe governmentand private sectorinindiato
ensure the widestpossiblereachof the sputnikvvaccine as part of the national inoculationeffort,
an effortestimated36crore Indianswill getthe Russiancovidvaccine sputnikvbythe endof the
march 2022 indiawill have approximatorymillionsdosesof vaccine
The cost of the vaccine is decidedbythe company
The importedvaccine hasbeenpricedatrs 948 per doses,how everincluding5per centgoodsand
servicestax ,the price of thisvaccine goesup to rs 995.40 per doses,DRLsays the price mightgo
downonce local suppliesbegin,itisunclearwhenthisisexpectedtohappen,whenlocal start
producingthenprice will lowascompanysays.
The price comparisonof 3 vaccine inindia
The covishield,manufacturedbyseruminstitute of india ischeaperthansputnikvat the moment,
it isprovidedtostatesat 300 per dose while itispricedat 600 per dose toprivate hospitals.Gov
gave free vaccination, bharatbiotech.scovaxinthe othercovidvaccine suppliedinindia isthe most
expersivecovid –19 vaccine inindia’sportpolioof vaccine sofar,itis pricedat RS 400 per dose for
statesand soldat RS 1200 perdose to private hospitals, anditis justnot that SPUTNIKv infocus ,
indiaislookingatmodernaandquad vaccine intiative underwhichvaccineswill be producedinthe
country,whenitcomesto constraintsforraw material forvaccinesfromthe us the issue has been
resolvedwithWashington.
200 crore dosesof vaccinescovid -19 vaccine inindiasoon thisis the new updatesgivesbythe
governmentof indiaandniti aayogandthe ministryof healthandwelfare.OnTuesday,the headof
the country covidtaskforce DR V.K.Paul estimatedthe emergingvaccine availabilityforthe period
of augustto Decemberata starting 216 crore more than 2 billiondosesof vaccine.
The government’sestimatedDRvkPAUL said thatwas basedon data submittedof 8 covid-19
vaccines,we have contactedof vaccinesforAUGUST – DECEMBER , inthe periodof , 216 crore doses
wouldavailableinindia,vaccine will be made available forall aswe move forward,drpaul saidthat
,
Vaccines doses status
Covishield 75 11cr dosesinmay- July
Covaxine 55 5cr dosesinmay-july

3. BioE 30 inphase 3 trials
Zyduscandila 5 inlastphase 3
SII NOVAVAX 20 approval pending
Bb nasal 10 inphase 1 -2
Gennova 6 in phase 1 -2
Sputnik 15.6 available now
Total 216cr
A massive capacityrampup will be neededbefore itisable tosupply95cr dosesbetweenaug-
Decembercovishield
The rampingup of covaxine productionwillalsodependsonthe efficiencyof the three PSUsthat will
be involvedinitsmanufacture.
The availabilityof biological Evaccine will dependslargelyonthe data from itsclinical trial.
OnJanuary 3 zydas candilasaid ithad receivedregulatoryapprovaltoinitate phase 3trialsof its
zycovd vaccine candidate,the Ahmedabadfirmisstill tosubmitefficacydataforitsvaccine
candidate.
At thisstage everywhere inthe worldthere isasymmetryonsupplydemandpaul saidthatbutwe
have to rememberitwill take time tocoverthe entire populationwe shouldacceptthe realitywith
humility.
The unitedstatessaidthathe has beenable togive at leastone dose of 46 percentpf itspopulation
and inGermanywhichhas a population8.3crore 34 percenthave receivedasingle dose ormore.
There for ittimestakes.
The continuingshortage of vaccinesinindiahashadan adverse falloutwithreportof a manin
maharastra’sjalnadistrictbeingadministered twodiff vaccines,the firsdose beingof vaxine while
the seconddose wascovishield.
Accordingto studyof preliminaryfindingsof the studyconductedbythe UKgovernmentand
universityof oxford,involvingadministeringvolunteerswithdosesof twodiff vaccinesitwasfound
that such recipientswere ata higherriskof adverse reactions,the studywaslaunchedinfabto
determine if mixingvaccinesgivesimmunityforalongerdurationandbetterproectionagainst
varients.
The study toldthattheygive a astra zenca vaccine andpifzerbiotechvaccine andvice versa,called
the com-covstudyit isfoundthat people receivingmixeddosesagesshowedmore frequent

4. reactionssuchas chills,fatigue, feverishness,headache,jointpain,malaise,musle ache,andpainat
the injectionsite.Ascomparedtopeople whoreceivedthe same vaccine inbothdosages.10% of
particepantsreportedservere fatigueforinstance ,comparedwithout3% forthose inoculatedwith
a single type of vaccine the researchshowsthat.
The study publishedinlancet,there’sapossibilitythatmixingvaccinescouldleadtoincrease inpost
immunisationabsencesfromworktoallow recipientstorecover.